Lucky Cement Limited has earned a net profit of Rs 26.53 billion during the last nine months of 2021, as per the company’s financial results for the period that terminated on March 31, 2021. The company’s profit grew by 20 percent as compared to Rs 22.15 billion in the same period a year ago.
This converts into earnings per share (EPS) of Rs 64.07 per share against Rs 56.36 per share recorded during the same period last year.
Moreover, with regard to a consolidated basis, the Company attained a net turnover of almost Rs 265.70 billion, 31.2% higher when compared to the same period the previous year’s turnover of Rs 202.46 billion.
Read more: Chinese companies to set up cement factories in Pakistan
During the nine months 2021-22 under analysis, the Company’s consolidated gross profit (referring to owners of the Holding Company) rose by 13.7% against the same period last year. However, in spite of the challenges because of growing production costs across all segments, Lucky Cement has been able to secure double-digit progress in its profitability.
Meanwhile, the credit for the increased Net Profit was mainly referred to the remarkable performance of the Group’s chemicals business and overseas cement segment. The Group’s Polyester, Pharmaceutical and Animal Health segments had succeeded to secure growths of 30.4%, 56.7%, and 95.9% respectively in operating results, against the same period last year, due to better sales mix, enhanced volumes, and new product launches in the pharmaceutical segment.
However, the export sales volumes of Lucky Cement declined by 18.0% to 1.56 million tons versus 1.90 million tons in the same period a year ago, on the back of constant instability in international coal prices and extremely high freight costs internationally. Therefore, overall sales volumes of the Company witnessed a decrease of 7.1% to reach 7.07 million tons during 9M 2021-22.
Regarding Company’s unconsolidated economic performance, the overall sales revenue rose by 19.6% against the same period last year. For every ton, the cost of sales of the Company hiked by 49.1% as compared to the same period the previous year.